Nextel Medical Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Nextel Medical Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | $0 | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | $0 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $0 | Aug 14, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Apr 30, 2012 | $0 | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | $0 | Aug 7, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | ($436.0K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($125.2K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($575) | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | ($6.07M) | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | ($100.6K) | Aug 7, 2012 |
| FY2012 | Apr 30, 2010 | ($5.7K) | Aug 7, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | ($467.9K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($125.2K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($1.5K) | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | ($5.99M) | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | ($95.4K) | Aug 7, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | ($169.7K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($9.3K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($884) | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | ($215.4K) | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | ($64.2K) | Aug 7, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | $58.3K | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | $0 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $1.6K | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | $5.9K | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | $71.2K | Aug 7, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | $444.8K | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | $214.3K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $90.7K | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | $280.3K | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | $102.5K | Aug 7, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | ($386.5K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($214.3K) | Aug 13, 2020 |
| FY2020 | Apr 30, 2018 | ($89.1K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2017 | ($273.9K) | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | ($274.4K) | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | ($31.3K) | Aug 7, 2012 |
| FY2012 | Apr 30, 2010 | ($5.7K) | Aug 7, 2012 |
| FY2012 | Apr 30, 2009 | $0 | Aug 7, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | ($9.08M) | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | ($8.65M) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($8.52M) | Aug 14, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | $0 | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | $0 | Aug 13, 2020 |
| FY2020 | Apr 30, 2018 | $1.6K | Aug 13, 2020 |
| FY2019 | Apr 30, 2017 | $2.5K | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | $5.9K | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | $71.2K | Aug 7, 2012 |
| FY2012 | Apr 30, 2010 | $4.9K | Aug 7, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Apr 30, 2020 | 249.84M | Aug 13, 2020 |
| FY2020 | Apr 30, 2019 | 249.78M | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | 249.78M | Aug 14, 2019 |
| FY2012 | Apr 30, 2012 | 48.83M | Aug 7, 2012 |
| FY2012 | Apr 30, 2011 | 97.50M | Aug 7, 2012 |